PPT-Evaluation of tolerability, pharmacokinetics, and anti-

r etroviral activity of MK8591 in treatmentnaïve HIV1infected adult subjects MK8591 EFdA Background Nucleoside reverse transcriptase translocation inhibitor

8591 subjects treatment dose subjects 8591 dose treatment teaes aes hiv ncs infected study decline single administered doses adverse

Presentation Embed Code

<iframe width="560" height="315" src="https://www.docslides.com/embed/637096" frameborder="0" allowfullscreen></iframe>

Download Presentation

Download Presentation The PPT/PDF document "Evaluation of tolerability, pharmacokine..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.